Literature DB >> 25902763

Serum 25-hydroxyvitamin D level and diabetic nephropathy in patients with type 2 diabetes mellitus.

Yan Peng1, Liu-Juan Li.   

Abstract

OBJECTIVE: Patients with chronic kidney disease have a very high prevalence of deficiency of 25-hydroxyvitamin D [25(OH)D]. We evaluate the association between 25(OH)D and diabetic nephropathy (DN) in a Chinese sample with type 2 diabetes mellitus.
METHOD: The subjects were patients with diabetes mellitus who were hospitalized at our hospital during the period from June 2012 to July 2014. Serum levels of 25(OH)D were tested at admission. DN was defined as a urinary albumin-to-creatinine ratio ≥30 mg/g in a random spot urine sample. Multivariate analyses were performed using logistic regression models.
RESULTS: We found that serum 25(OH)D levels were significantly lower in diabetes with DN as compared to without DN [8.5 (IQR 6.8-11.3) vs. 13.9 (IQR 11.2-18.2) ng/ml, P < 0.0001]. Based on the ROC curve, the optimal cutoff value of serum 25(OH)D levels as an indicator for diagnosis of DN was projected to be 10.5 ng/ml, which yielded a sensitivity of 82.6 % and a specificity of 72.7 %, with the area under the curve at 0.807 [95 % confidence interval (CI) 0.764-0.849]. Multivariate logistic regression analysis adjusted for common risk factors showed that with serum 25(OH)D level ≤10.5 ng/ml was an independent indicator of DN [odds ratio (OR) = 6.559; 95 % CI 2.864-11.368].
CONCLUSIONS: Our findings suggested that diabetes with DN had lower serum 25(OH)D levels and that determination of 25(OH)D statuses might be used to identify patients at increased risk of developing nephropathy complications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25902763     DOI: 10.1007/s11255-015-0983-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Nephropathy in diabetes.

Authors:  Mark E Molitch; Ralph A DeFronzo; Marion J Franz; William F Keane; Carl Erik Mogensen; Hans-Henrik Parving; Michael W Steffes
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke.

Authors:  Wen-Jun Tu; Sheng-Jie Zhao; Dong-Jiang Xu; Hui Chen
Journal:  Clin Sci (Lond)       Date:  2014-03       Impact factor: 6.124

3.  Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis.

Authors:  Guilin Qiao; Juan Kong; Milan Uskokovic; Yan Chun Li
Journal:  J Steroid Biochem Mol Biol       Date:  2005-06       Impact factor: 4.292

Review 4.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 5.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

6.  25-hydroxyvitamin D levels, race, and the progression of kidney disease.

Authors:  Michal L Melamed; Brad Astor; Erin D Michos; Thomas H Hostetter; Neil R Powe; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

Review 7.  Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.

Authors:  Yan Chun Li; Guilin Qiao; Milan Uskokovic; Wei Xiang; Wei Zheng; Juan Kong
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

8.  The oxidative stress status in diabetes mellitus and diabetic nephropathy.

Authors:  Hong-zhi Pan; Lin Zhang; Mei-yi Guo; Hong Sui; Hui Li; Wei-hua Wu; Nai-qiang Qu; Mei-hua Liang; Dong Chang
Journal:  Acta Diabetol       Date:  2009-05-28       Impact factor: 4.280

9.  25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.

Authors:  Gema Fernández-Juárez; José Luño; Vicente Barrio; Soledad García de Vinuesa; Manuel Praga; Marian Goicoechea; Vicente Lahera; Luisa Casas; Jesús Oliva
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 8.237

10.  Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals.

Authors:  Ling Lu; Zhijie Yu; An Pan; Frank B Hu; Oscar H Franco; Huaixing Li; Xiaoying Li; Xilin Yang; Yan Chen; Xu Lin
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 17.152

View more
  16 in total

1.  Lower serum 25-hydroxyvitamin D levels are associated with impaired glomerular filtration rate in type 2 diabetes patients.

Authors:  Angélica Dall'Agnol; Letícia de Almeida Brondani; Vítor da Agostim Cancelier; Eduardo Guimarães Camargo; Sandra Pinho Silveiro
Journal:  Ther Adv Endocrinol Metab       Date:  2020-07-27       Impact factor: 3.565

2.  Biochemical markers of mineral bone disorder in South African patients on maintenance haemodialysis.

Authors:  Bala Waziri; Raquel Duarte; Saraladevi Naicker
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

3.  Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5.

Authors:  César Augusto Restrepo Valencia; José Vicente Aguirre Arango
Journal:  Colomb Med (Cali)       Date:  2016-09-30

Review 4.  Is Hypovitaminosis D Related to Incidence of Type 2 Diabetes and High Fasting Glucose Level in Healthy Subjects: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Shamaila Rafiq; Per Bendix Jeppesen
Journal:  Nutrients       Date:  2018-01-10       Impact factor: 5.717

5.  Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Shamaila Rafiq; Per Bendix Jeppesen
Journal:  Nutrients       Date:  2018-08-28       Impact factor: 5.717

6.  Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy.

Authors:  Ahmed El-Abd Ahmed; Hala M Sakhr; Mohammed H Hassan; Mostafa I El-Amir; Hesham H Ameen
Journal:  Diabetes Metab Syndr Obes       Date:  2019-05-14       Impact factor: 3.168

7.  Association between serum 25-hydroxyvitamin D and diabetic kidney disease in Chinese patients with type 2 diabetes.

Authors:  Shaofeng Xie; Liji Huang; Wen Cao; Yongxin Hu; Hongping Sun; Lin Cao; Kemian Liu; Chao Liu
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

Review 8.  Role of Vitamin D Status in Diabetic Patients with Renal Disease.

Authors:  Guido Gembillo; Valeria Cernaro; Antonino Salvo; Rossella Siligato; Alfredo Laudani; Michele Buemi; Domenico Santoro
Journal:  Medicina (Kaunas)       Date:  2019-06-13       Impact factor: 2.430

9.  Autophagy and mTOR Pathways Mediate the Potential Renoprotective Effects of Vitamin D on Diabetic Nephropathy.

Authors:  Suzan A Khodir; Rehab M Samaka; Omnia Ameen
Journal:  Int J Nephrol       Date:  2020-05-13

10.  A Nonlinear Relationship Between Serum 25-Hydroxyvitamin D and Urine Albumin to Creatinine Ratio in Type 2 Diabetes: A Cross-Sectional Study in China.

Authors:  Qian Liang; Haofei Hu; Han Wu; Xuan Chen; Wei Wang; Ying Le; Shufen Yang; Lijing Jia
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-09       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.